What Meril Life does

Meril Life (legal entity: Meril Life Sciences India Pvt Ltd) is an India-based global medical device company founded in 2006 in Vapi, Gujarat. The company designs, manufactures, and distributes clinically relevant medical devices across six therapeutic verticals: vascular intervention (including the Myval transcatheter aortic heart valve series and BioMime sirolimus-eluting coronary stents), cardiac surgery, orthopedics (Freedom, Opulent, and Latitud knee and hip replacement systems), endo-surgery (MIRUS staplers, trocars, meshes, sutures, and adhesives), surgical robotics (MIZZO Endo 4000 and Misso AI-powered robotic platforms), diagnostics (CQ5 analyzers with auto-loader), and urology. The portfolio rests on 500+ patents and is supported by 494 published clinical publications, with the LANDMARK RCT (published in The Lancet) validating the Myval series against established Western THV benchmarks.

The company commercializes its devices through 35+ wholly owned subsidiaries and field-sales teams operating across 150+ countries, with named subsidiaries in the US (Meril Inc., Maxx Orthopedics), Germany, the UK, Italy, Spain, Brazil, Mexico, Russia, Turkey, Egypt, South Africa, China, Vietnam, Malaysia, Indonesia, Australia, South Korea, Sweden, Israel, and Bangladesh, plus training academies in Madrid, Delhi, and Kochi. The primary customer segments are interventional cardiologists, orthopedic surgeons, and general/laparoscopic surgeons, with secondary institutional buyers including state health departments (e.g., Jharkhand procurement of fully automatic pathology machines) and tertiary hospitals such as Sir Ganga Ram Hospital and GEM Hospital Chennai.

Meril generates revenue through direct hardware sales of medical devices plus long-term service and maintenance contracts (e.g., 10-year bundled maintenance on government pathology installations), priced via quote-based negotiation with hospitals and government institutions. Pricing follows enterprise/government procurement cadence rather than list pricing. The company is owned at the parent level by Micro Life Sciences and is backed by Warburg Pincus (USD 210 million in February 2022 at a USD 1.8 billion valuation) and the Abu Dhabi Investment Authority (USD 200 million for ~3% in July 2025 at a USD 6.6 billion enterprise value). Operational scale includes 12,000+ employees, 400+ R&D personnel, and a 10,00,000+ sq ft headquarters facility.

Name

Meril Life

Legal name

Meril Life Sciences India Pvt Ltd

Website

https://merillife.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Meril Life is an India-based global medical device company founded in 2006 that designs, manufactures, and distributes clinically validated devices across vascular intervention, orthopedics, endo-surgery, surgical robotics, diagnostics, and urology, serving physicians, hospitals, and government health systems in 150+ countries via 35+ subsidiaries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Vascular intervention devices
• Orthopedic implants
• Surgical robotics
• Endoscopic surgery instruments
• Diagnostic analyzers

Headquarters

HQ city

Vapi

HQ country

India

HQ region

Asia

Offices16 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Manufacturing and selling medical devices including vascular intervention products (stents, balloon catheters, heart valves), orthopedic implants, surgical robots, diagnostics equipment, and endo-surgery products globally through subsidiaries and distribution networks.
2. Equipment & Maintenance Services: Sale of pathology testing equipment with bundled 10-year maintenance and operational support services to government healthcare institutions.
3. Service and Support Contracts: Long-term maintenance services bundled with medical equipment sales, including 10-year maintenance commitments for pathology machines installed in government hospitals.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Meril Life designs, manufactures, and distributes clinically relevant medical devices across multiple specialties including vascular intervention (transcatheter heart valves, coronary and peripheral stents, balloon catheters, closure devices), orthopedics (knee and hip replacement systems), surgical robotics (MIZZO Endo 4000, Misso), endo-surgery (MIRUS staplers, meshes, sutures, trocars), in-vitro diagnostics (CQ5 Ultima analyzers), and urology. The company sells primarily to hospitals, healthcare professionals, and government healthcare institutions through its own subsidiaries across 150+ countries.

Product overview

Meril Life Sciences is a global medical device company founded in 2006, dedicated to designing and manufacturing clinically relevant, cutting-edge medical devices. The company's product portfolio spans multiple therapeutic areas including Vascular Intervention (featuring the Myval THV series for TAVR, BioMime sirolimus-eluting stents, coronary and peripheral vascular devices, and congenital heart closure devices), Cardiac Surgery (including Dafodil Pericardial Bioprosthesis and Nautica Intracoronary Shunt), Orthopedics (Freedom and Opulent knee/hip replacement systems, Latitud hip system), Endo-Surgery (MIRUS staplers, trocars, meshes, sutures, and surgical adhesives), Surgical Robotics (MIZZO Endo 4000 robotic-assisted surgery system), Diagnostics (CQ5 Ultima analyzers), and Urology (comprehensive stent and catheter portfolio). The company operates across more than 150 countries through 35+ owned subsidiaries and maintains over 500 patents.

Differentiator

Problem solved

Functional benefit

Brands

• Myval: India's first indigenously developed transcatheter aortic heart valve series for minimally invasive aortic valve replacement
• BioMime
• Mizzo Endo 4000
• MIRUS
• Treatment Zaroori Hai
• Add More To Life

Products and services

• Myval THV Series

Quantifiable outcome

• Myval THV series demonstrated comparable clinical efficacy with lowest incidence of moderate aortic regurgitation compared to Sapien and Evolut THV series in LANDMARK trial
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Micro Life SciencescoreOthersParent company of Meril Life Sciences, serving as the holding entity for the medical device business operations.
• Medical Device Parks (Government)coreStrategic or Co-development PartnerProminent domestic manufacturer mentioned alongside government initiatives including PLI Scheme (Rs 3,420 crore outlay), six approved Medical Device Parks, and 100% FDI allowance. Companies like Meril exemplify the sector's move toward high-technology, globally certified production.
• Gujarat Rajya Institution for Transformation (GRIT)minorGTM or Marketing PartnerGRIT and Export Promotion Council for Medical Devices (EPCMD India) jointly hosted 'Gujarat to Global: Empowering the MedTech Ecosystem' conference with Meril as industry participant discussing regulatory pathways and export competitiveness.
• Export Promotion Council for Medical Devices (EPCMD India)minorGTM or Marketing PartnerIndustry body jointly hosting MedTech sector conference with GRIT, bringing together policymakers, regulators, and industry leaders including Meril Life Sciences to discuss regulatory pathways and export competitiveness.
• Industry Conference ParticipantsminorStrategic or Co-development PartnerConference participants including SMT, BPL, Philips India, Wipro GE Healthcare, and Panacea Medical Technologies representing the broader MedTech ecosystem in India.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Edwards Lifesciences: Global leader in transcatheter heart valves (Sapien THV series) — directly competes with Meril's Myval THV in the structural-heart market and was the comparator arm in Meril's LANDMARK RCT. Most relevant direct peer for the Myval franchise.
• Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform. Direct competitor to Meril's MIZZO Endo 4000 and Misso robotic systems; benchmark for the robotic-surgery business model Meril is entering.
• Sahajanand Medical Technologies: India-headquartered competitor specializing in drug-eluting coronary stents and vascular intervention devices. Closest Indian-market direct peer, with overlapping product lines in coronary and peripheral stents.
• MicroPort Scientific: China-headquartered global medtech with overlapping portfolios in orthopedic implants, vascular intervention (stents, TAVR), and surgical robotics. Comparable emerging-market challenger profile and product breadth to Meril.

Broad incumbents

• Medtronic: Largest global medical device incumbent with the Evolut TAVR series, broad vascular intervention, orthopedic, surgical, and diabetes portfolios. Direct competitor to Myval (Evolut comparator in LANDMARK) and a benchmark for Meril's global commercial scale.
• Boston Scientific: Global medtech incumbent with overlapping portfolios in interventional cardiology (drug-eluting stents, structural heart), peripheral vascular, and endo-surgery. Comparable breadth and direct competition in vascular intervention and endoscopy categories.
• Stryker: Global leader in orthopedics (knee/hip replacement, trauma) and surgical equipment. Direct competitor to Meril's Freedom, Opulent, and Latitud joint-replacement systems and the Misso robotic knee platform.
• Abbott: Diversified global medtech with strong presence in vascular intervention (drug-eluting stents, structural heart), diagnostics, and diabetes care. Competes with Meril in coronary stents, TAVR adjacency, and IVD analyzers.
• Zimmer Biomet: Pure-play orthopedic medtech (knee, hip, trauma) and a direct competitor to Meril's orthopedic implant portfolio. Comparable product breadth in joint reconstruction and adjacent robotic-assisted surgery platforms.
• Terumo: Japanese global medtech with strong vascular intervention (stents, catheters) and hospital systems businesses. Direct comparator in drug-eluting stents, balloon catheters, and peripheral vascular devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCpPK08HhfAMqjKlTVSFJN1A
• Facebookfacebook.com/MerilLifeSciences
• LinkedInlinkedin.com/company/meril-life-sciences-india-pvt-ltd
• Instagraminstagram.com/merilglobal
• Xx.com/merillife

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries30 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meril Life